Home > Journals > Minerva Ortopedica e Traumatologica > Past Issues > Minerva Ortopedica e Traumatologica 2002 December;53(4) > Minerva Ortopedica e Traumatologica 2002 December;53(4):195-204

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

REVIEWS   

Minerva Ortopedica e Traumatologica 2002 December;53(4):195-204

Copyright © 2002 EDIZIONI MINERVA MEDICA

language: Italian

High-grade osteosarcoma of the extremities

Fagioli F., Palmero A., Berger M., Gastaldo L., Pessolano R., Berta M., Brach Del Prever A., Madon E.


PDF


The prognosis of patients with high grade osteosarcoma has greatly improved over the past 25 years with overall survival rates rising from 15% to 70%. This improvement is attributed to: 1) the effect of preoperative chemotherapy; 2) the introduction of aggressive chemotherapy with various combinations of high-dose methotrexate, adriamycin, cisplatinum and ifosfamide; 3) the identification of the relationship of dose-response between methotrexate, adriamycin, cisplatinum and osteosarcoma cells; 4) the recognition of the main prognostic factor, such as the histological response to preoperative chemotherapy, which might change postoperative chemotherapy. In this review, the therapeutic protocol for high grade osteosarcoma localized at the extremities, for metastatic osteosarcoma at diagnosis and for relapsed osteosarcoma will be briefly explained.

top of page